Clinical Trial Update: Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients [Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 3 study evaluating the safety and tolerability of rasagiline in advanced Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• RASAGILINE (rasagiline)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED